1. Home
  2. PDSB vs ICCH Comparison

PDSB vs ICCH Comparison

Compare PDSB & ICCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • ICCH
  • Stock Information
  • Founded
  • PDSB 2005
  • ICCH 1950
  • Country
  • PDSB United States
  • ICCH United States
  • Employees
  • PDSB N/A
  • ICCH N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • ICCH Property-Casualty Insurers
  • Sector
  • PDSB Health Care
  • ICCH Finance
  • Exchange
  • PDSB Nasdaq
  • ICCH Nasdaq
  • Market Cap
  • PDSB 84.2M
  • ICCH 68.8M
  • IPO Year
  • PDSB N/A
  • ICCH 2017
  • Fundamental
  • Price
  • PDSB $1.45
  • ICCH $23.25
  • Analyst Decision
  • PDSB Strong Buy
  • ICCH
  • Analyst Count
  • PDSB 3
  • ICCH 0
  • Target Price
  • PDSB $14.00
  • ICCH N/A
  • AVG Volume (30 Days)
  • PDSB 296.4K
  • ICCH 5.7K
  • Earning Date
  • PDSB 11-14-2024
  • ICCH 03-03-2025
  • Dividend Yield
  • PDSB N/A
  • ICCH N/A
  • EPS Growth
  • PDSB N/A
  • ICCH 42.86
  • EPS
  • PDSB N/A
  • ICCH 2.16
  • Revenue
  • PDSB N/A
  • ICCH $92,541,259.00
  • Revenue This Year
  • PDSB N/A
  • ICCH N/A
  • Revenue Next Year
  • PDSB N/A
  • ICCH N/A
  • P/E Ratio
  • PDSB N/A
  • ICCH $10.77
  • Revenue Growth
  • PDSB N/A
  • ICCH 14.09
  • 52 Week Low
  • PDSB $1.30
  • ICCH $14.78
  • 52 Week High
  • PDSB $6.68
  • ICCH $23.96
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 34.16
  • ICCH 47.12
  • Support Level
  • PDSB $1.37
  • ICCH $23.28
  • Resistance Level
  • PDSB $1.50
  • ICCH $23.47
  • Average True Range (ATR)
  • PDSB 0.13
  • ICCH 0.06
  • MACD
  • PDSB 0.00
  • ICCH -0.02
  • Stochastic Oscillator
  • PDSB 28.03
  • ICCH 10.20

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About ICCH ICC Holdings Inc.

ICC Holdings Inc is a specialty insurance carrier underwriting commercial multi-peril, liquor liability, worker's compensation, and umbrella liability coverages for the food and beverage industry. The company markets its products through a network of independent agents in Colorado, Illinois, Indiana, Iowa, Kansas, Minnesota, Missouri, Pennsylvania, Ohio, and Wisconsin.

Share on Social Networks: